bioAffinity Technologies, Inc. (BIAF) vs GeoVax Labs, Inc. (GOVX)
A side-by-side comparison of bioAffinity Technologies, Inc. and GeoVax Labs, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIAF
bioAffinity Technologies, Inc.
$5.94HealthcareDelayed quote: Oct 6, 2026, 10:44 AM EDT
GOVX
GeoVax Labs, Inc.
$0.30HealthcareDelayed quote: Oct 6, 2026, 10:39 AM EDT
Not enough overlapping price history to compare BIAF and GOVX.
BIAF vs GOVX: by the numbers
- •BIAF is the larger company ($2M vs $2M market cap).
- •Both run net losses; BIAF's is the smaller (-257.33% vs -862.34% net margin).
Metrics side by side
Valuation
| Metric | BIAF | GOVX |
|---|---|---|
| P/S ratio | 0.42 | N/A |
| P/B ratio | 0.66 | 1.26 |
Profitability
| Metric | BIAF | GOVX |
|---|---|---|
| Gross margin | 23.21% | -628.02% |
| Operating margin | -171.58% | -869.34% |
| Net margin | -257.33% | -862.34% |
| ROE | -402.92% | -1160.10% |
| ROIC | -237.93% | -985.20% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.